S. Tyčiaková

Silencing of carbonic anhydrase I enhances the malignant potential of exosomes secreted by prostatic tumour cells

O. Benada, Ľ. Škultéty, Radivojka Bánová Vulić, 2019, Journal of cellular and molecular medicine.

Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.

M. Matúšková, V. Altanerová, C. Altaner, 2007, Cancer research.

Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice

M. Matúšková, J. Jakubikova, V. Altanerová, 2008, The journal of gene medicine.

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

M. Matúšková, Z. Čierna, Z. Kozovska, 2015, Journal of Experimental & Clinical Cancer Research.

Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells

M. Matúšková, J. Gursky, S. Tyčiaková, 2016, Cell Communication and Signaling.

3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment.

M. Matúšková, Z. Kozovska, S. Tyčiaková, 2015, Neoplasma.

Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft

M. Matúšková, S. Tyčiaková, L. Kucerova, 2015, The journal of gene medicine.

Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment

M. Matúšková, Z. Kozovska, S. Tyčiaková, 2018, Cancer Gene Therapy.